- Written by ClinicalTrials.gov
- Category: Bone diseases
Intervention: Drug: E2/LNG oral (Wellnara, BAY86-5029)
Sponsor: Bayer
Recruiting - verified July 2011
- Details
Improving orthopaedic care, education and research using Internet technologies
© 1999-2017 Orthogate. All rights reserved.